The role of GB virus C/hepatitis G virus (GBV-C/HGV) in adult and pediatric liver disease is unclear. We detected serum GBV-C/HGV RNA by reverse transcriptase polymerase chain reaction in 1 (3%) of 38 cholestatic infants, in 4 (4%) of 95 children without liver disease, and in none of 30 children with autoimmune hepatitis. One cholestatic infant had antibodies, presumably maternal, to GBV-C/HGV. Sequence analysis of a nonstructural 3 region fragment suggested that mother-to-infant transmission was the route of infection for the cholestatic infant. The four infected children without liver disease had normal liver function test results and lacked risk factors for bloodborne infections. Thus, the detection of GBV-C/HGV RNA among children with and without liver disease suggests that chronic GBV-C/ HGV infections may be established early in life, possibly by mother-to-infant transmission. This may explain in part the high prevalence of serum GBV-C/HGV RNA and antibodies in healthy adults.
The recently described GB virus C/hepatitis G virus (GBV-70 days; range, 30 -180 days; table 1) with clinical and biochemical signs of cholestasis. They were referred to our tertiary C/HGV) [1, 2] appears to be more prevalent in healthy adults than is the closely related hepatitis C virus [3 -5] . Knowledge unit for pediatric hepatology and investigated for known genetic, metabolic, and infectious causes of neonatal cholestasis about the transmission routes of GBV-C/HGV is limited, and the importance of this virus in adult as well as pediatric liver [11] . Fourteen of these 38 infants had extrahepatic biliary atresia; the other 24 had intrahepatic forms of cholestasis. Of these, disease has been debated [3, 4, 6 -8] .
We and others have recently reported on mother-to-infant nine had defined genetic and/or metabolic diseases causing cholestasis, including a 1 -antitrypsin deficiency in two, progrestransmission of GBV-C/HGV [9, 10] . However, the clinical importance of GBV-C/HGV infections at this early age is not sive familial intrahepatic cholestasis in two, inborn error of fatty acid metabolism in two, Alagille syndrome (syndromic known. In infants õ6 months of age, cholestasis is one of the most common expressions of liver disease. This is generally paucity of intrahepatic bile ducts) in one, Aagenaes syndrome (chronic intrahepatic cholestasis with lymphoedema) in one, referred to as neonatal cholestasis [11] . Despite a long list of possible causes, the etiology of neonatal cholestasis remains and severe combined immunodeficiency in one patient. For the other 15 patients, no certain cause of the cholestasis was found. unknown in ú50% of cases [11] . This is problematic, since the mortality and morbidity is high. In previous studies, conHowever, six of them had signs of ongoing cytomegalovirus (CMV) infection, that is, IgM to CMV was detected in serum genital or perinatal viral infections other than those with GBV-C/HGV have been linked to neonatal cholestasis [12 -14] .
and/or CMV was isolated in urine [14] . The second group consisted of 95 children, mainly toddlers The aim of the present study was to investigate the prevalence and possible routes of transmission of GBV-C/HGV in (42 boys and 53 girls; median age, 2.2 years; range, 0.6 -9.2 years; with the GBV-C/HGV sequences derived from his mother (figure 1).
NOTE. GBV-C/HGV Å GB virus C/hepatitis G virus.
In the group of children without liver disease, three of the * Only 26 sera were analyzed for antibody to GBV-C/HGV envelope 2 glycoprotein; GBV-C/HGV RNA was not detected in the antibody-positive four GBV-C/HGV RNA -positive patients (three boys and one serum sample. girl) had celiac disease. This was confirmed by three smallbowel biopsies, which is the internationally agreed-upon diagnostic criterion for celiac disease. The fourth child was suspected of having celiac disease; however, only one small bowel as described earlier [9] . Positive samples were then confirmed with primers from the nonstructural 3 (NS3) region [9] , and biopsy was done. The first three patients were analyzed at the time of their third biopsy (at 3.6, 3.9, and 4.1 years of age, the amplified product was sequenced by use of the Cy 5 Auto Read sequencing kit and an ALF Express DNA sequencer respectively), and the fourth at the time of his first and only biopsy (at the age of 1.2 years). All four were breast-fed; none (Pharmacia Biotech, Uppsala, Sweden). Phylogenetic analysis of the NS3 region sequences was done with the GeneWorks of them had received any blood products. Liver function tests were repeatedly normal in all four. Phylogenetic analysis con-2.3 software package (Intelligenetics, Mountain View, CA) and the unweighted pair group method with arithmetic mean.
firmed that the amplified fragments were of GBV-C/HGV origin. No close genetic relation between the GBV-C/HGV seAntibodies to GBV-C/HGV envelope 2 glycoprotein were analyzed in stored sera from all patients, except for 12 infants quences from the five children was observed (figure 1). Antibody to GBV-C/HGV envelope 2 glycoprotein was rein the group with neonatal cholestasis, by use of a commercially available EIA (Anti-HGenv; Boehringer Mannheim, Mannproducibly detected in the serum from only one patient, belonging to the group with neonatal cholestasis. The same serum heim, Germany). The assay was done according to the manufacturer's instructions. Only samples that were reproducibly sample was negative for GBV-C/HGV RNA by PCR. The patient was diagnosed as having extrahepatic biliary atresia. reactive were considered positive. Samples with reactivities that could not be reproduced and those with single borderline
The serum sample was drawn at 2 months of age, before any surgical procedure, and he had not received any blood products. reactivity were regarded as negative.
Later a portoenterostomy was done, and he became anicteric at 5 months of age. On follow-up at 4.5 years of age, he had Results compensated chronic liver disease. GBV-C/HGV RNA was detected in the serum from 1 (3%) of the 38 children with neonatal cholestasis, from 4 (4%) of Discussion the 95 patients without liver disease, and from none of the 30 patients with AIH.
The significance of GBV-C/HGV in liver disease has been questioned [3, 4] . However, a recent report showed an associaThe GBV-C/HGV RNA -positive patient with neonatal cholestasis was delivered vaginally after a normal pregnancy and tion between GBV-C/HGV and elevated biochemical markers for cholestatic liver disease in adults [15] . Since the etiology was breast-fed. The boy had not received any blood products.
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02-24-99 11:15:03 cida UC: CID have been sufficient to cause his cholestasis [14] . However, the possibility that both viral infections were linked to the development of neonatal cholestasis cannot be ruled out. Since genetically similar GBV-C/HGV RNA was found in both the mother and the cholestatic infant, vertical or early horizontal transmission seems the most probable route of infection. For yet-unknown reasons, mother-to-infant transmission of this virus is thought to occur more frequently than with the related hepatitis C virus [9, 10] . As we and others have shown, vertical infection with GBV-C/HGV often results in asymptomatic infection, with persistent viremia [9, 10] . However, in analogy with children with vertically transmitted hepatitis B virus or hepatitis C virus infections, one cannot exclude that perinatally acquired GBV-C/HGV infection could cause liver damage in adulthood. Additionally, in the serum from one of the cholestatic infants, antibodies to GBV-C/HGV envelope 2 glycoprotein were detected at 2 months of age. Because of the early age, we assume that these were passively transferred maternal antibodies.
As in adults, the rate of GBV-C/HGV RNA seropositivity in children is high in selected groups at risk for bloodborne infections [18] . The situation in healthy children outside the risk groups is largely unknown. This is of general interest, considering the high incidence in healthy adults [3 -5] . Recently, Chen et al. [18] reported that in a group of healthy children, aged 0.5 -12 years, 1% were GBV-C/HGV RNApositive. The rate of 4.2% found in the present study is even higher, and results such as these suggest that many seropositive adults might have been infected with GBV-C/HGV at birth or during early childhood. mission could not be addressed.
The advantage of testing patients without liver disease who were evaluated for malabsorption was that venous blood sampling was part of the routine clinical investigation. Blood samof neonatal cholestasis is often unknown, the importance of a newly described viral agent such as GBV-C/HGV needs to be pling in healthy children is generally not accepted for ethical reasons. It should be noted that the etiology of celiac disease examined. In the present study, 1 of 38 patients with neonatal cholestasis was GBV-C/HGV RNA -positive. This rate of serois still unknown; for example, adenovirus infection has been implicated in the pathogenesis of this enteropathy [19] . positivity was similar to that of children without liver disease, suggesting that GBV-C/HGV is not an important etiologic facWhether GBV-C/HGV has a trophism for or is in some way pathogenic for the gut remains to be investigated. tor for the development of neonatal cholestasis. For comparison, in a previous study of patients with neonatal cholestasis,
The patients with AIH were analyzed for the presence of GBV-C/HGV for two reasons. The first was that the etiology we found no association with hepatitis B virus or hepatitis C virus infections [14] , and similar results were reported by others of AIH still is not known, and theoretically GBV-C/HGV could be a triggering factor for that disease. The second reason was [16, 17] .
The GBV-C/HGV RNA -positive infant with neonatal chothat we sought a group of older children, mostly teenagers, to compare the rate of GBV-C/HGV RNA -positive patients in lestasis also had ongoing CMV infection, which in itself might / 9c63$$mr19 02-24- 
